subscribe
 

Mouse bispecific antibody reagents launched

Absolute Antibody launches mouse bispecific antibody reagents: novel fully murine knob-into-hole antibodies for immunotherapy research and...

Drug discovery collaboration

Sygnature Discovery, a leading independent integrated drug discovery and pre-clinical services company, has announced a collaboration with...

Mini-centrifuge opens new organ-on-chip possibilities

A simple innovation the size of a grain of sand means we can now analyse cells and tiny particles as if they were inside the human body

Automated endotoxin detection

Lonza’s fully automated plate-based robotic solution enables simple, fast and reliable endotoxin detection

HD reactors aid workflow

Walk-away process development with Syrris' Atlas reactors: case study shows HD reactors accelerate product development

New XF-platform drug formulations

Biotech firm Destiny Pharma appoints MedPharm as expert partner to develop new XF-platform drug formulations

Platform for ultrahigh-content imaging

Early access program to fully automated, cyclic, high-content immunofluorescence-based imaging

New spheroid-forming human hepatocytes

Lonza’s newly launched spheroid-forming human hepatocytes facilitate improved in vitro liver model systems

New project to improve ovarian cancer treatment

Porvair Sciences reports on its involvement in a new £2.6 million project led by Swansea University (UK) that aims to dramatically improve...

Breakthrough opens path to new vaccine for HIV

A CEA-Leti breakthrough has opened the path to a new vaccine for using lipid-nanoparticle-delivery technology

New pooled donor suspension hepatocytes

Lonza’s new pooled donor suspension hepatocytes enable the next level of reliability, robustness and customisability

Characterising liposomes

Testa Analytical Solutions reports on customers using its Nanobrook ZetaPALS instrument for characterising liposomes and liposome-drug...

Drug discovery institute identifies Huntington's leads

Alborada Drug Discovery Institute identifies advanced Huntington's leads using BioAscent's Compound Cloud library

New biological entity characterisation

Sartorius Stedim Biotech has announced that it will now be offering services for characterisation of new biological entities (NBE)

Experimental cell lines introduced

Experimental cell lines help screening for CAR T therapies - AMS Bio has added new experimental cell lines to its CAR T cell research range....

Drug therapy for spinal chord injury shows promise

Embedded Chondroitinase ABC shows promise for spinal injury treatment

Joint study to prove efficacy of first prognostic test for IBD

PredictImmune and the Crohn’s & Colitis Foundation announce a joint study to validate and prove efficacy of first prognostic test for IBD...

Multi-target drug discovery deal announced

Sygnature Discovery announces multi-target drug discovery deal with Sitryx Therapeutics

Drug development technology licensed

DefiniGen licenses CRISPR-Cas9 gene editing technology from Broad Institute to develop cell models for optimised metabolic disease drug...

Human cell models could potentially replace animal experiments

Elpis Biomed human cell models could potentially replace animal experiments in drug discovery, says Dr Jonathan Milner

Pages

Newsbrief

FREE NEWSBRIEF SUBSCRIPTION

To receive the Scientist Live weekly email NewsBrief please enter your details below

Twitter Icon © Setform Limited
subscribe